Hexarelin

What is Hexarelin?

Hexarelin, a synthetic growth hormone secretagogue (GHS), belongs to a class of peptides designed to stimulate the release of growth hormone (GH). Hexarelin is part of a group of compounds known as growth hormone-releasing peptides (GHRPs), which bind to ghrelin receptors, also known as growth hormone secretagogue receptors (GHS-R). These receptors signal the pituitary gland to release GH.

Research on Hexarelin has examined its capacity to produce a sustained increase in GH levels in experimental settings. It has been studied in preclinical models exploring GH signaling, metabolism and tissue repair, including models of growth hormone deficiency.

Areas of Hexarelin Research

Hexarelin’s GH-releasing activity has made it a subject of study in several research areas:

  • Muscle Tissue Models Researchers have studied the effects of GH elevation on lean tissue and protein synthesis in laboratory models.
  • Metabolic Research Growth hormone plays a key role in regulating metabolism, and Hexarelin is used to study GH-related effects on fat oxidation in experimental systems.
  • Tissue Repair Studies Hexarelin has been examined in preclinical models of tissue repair.
  • Bone Research GH is involved in bone metabolism, and GH secretagogues are studied in models of bone density.
  • Cardiovascular Research Some animal studies have reported cardioprotective activity for Hexarelin, an area that remains under investigation.
  • Dermatology Models Because GH is involved in collagen production, GH secretagogues are of interest in skin research.

Who Studies Hexarelin?

Hexarelin is used by researchers investigating growth hormone secretagogue receptors and GH signaling.

Typical Research Applications:

  • Laboratory studies of GH release and GHS-R receptor pharmacology.
  • Preclinical models of growth hormone deficiency and metabolic regulation.
  • Animal studies of cardiac tissue and cardioprotection.
  • Experimental models of tissue repair.

Hexarelin Research Notes

  • Hexarelin is a synthetic growth hormone secretagogue that acts on the ghrelin (GHS) receptor.
  • Preclinical studies have examined GH release and reported cardioprotective activity in animal models.
  • Water retention has been reported as an adverse observation in published studies, and long-term safety data are limited.
  • Hexarelin is not FDA-approved and is supplied only as a lyophilized research compound.

All products referenced are sold strictly for laboratory research use only and are not for human or veterinary consumption.

Shopping Cart
Scroll to Top